---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-24-000014"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2024-03-14T23:59:59+00:00"
generated_at: "2026-06-04T19:39:51.628283+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics elects Anne Phillips as director; Fry and Weiner resign

## Summary
- Anne Phillips elected director effective March 13, 2024; will chair Compensation Committee and serve on Audit Committee.
- John Fry and Howard Weiner resigned as directors effective upon filing of the 2023 Annual Report on March 13, 2024.
- Ms. Phillips is independent under Nasdaq rules and will enter standard indemnification agreement.

## SEC filing metadata
- accession: 0001641489-24-000014
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2024-03-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148924000014/0001641489-24-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148924000014/vtvt-20240313.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-24-000014
- JSON: https://secwatch.observer/filing/0001641489-24-000014.json
- Plain text: https://secwatch.observer/filing/0001641489-24-000014.txt

## Key facts
- Executive change
  Anne Phillips was elected as director at vTv Therapeutics Inc..
  - Action: elected
  - Role: director
  source text: On March 12, 2024, Anne Phillips was elected as director of vTv Therapeutics, Inc. (the “Company”), effective and contingent on the filing of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, which occurred on March 13, 2024 (the “2023 Annual Report”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1641489/000164148924000014/0001641489-24-000014-index.htm
- Executive change
  Howard Weiner resigned as director at vTv Therapeutics Inc..
  - Action: resigned
  - Role: director
  source text: John Fry and Howard Weiner resigned from their director roles effective upon the filing of the 2023 Annual Report.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1641489/000164148924000014/0001641489-24-000014-index.htm
- Executive change
  John Fry resigned as director at vTv Therapeutics Inc..
  - Action: resigned
  - Role: director
  source text: John Fry and Howard Weiner resigned from their director roles effective upon the filing of the 2023 Annual Report.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1641489/000164148924000014/0001641489-24-000014-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.